Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

SEC Filing · POS AM

PAPA MEDICAL INC

SEC Filing

Filed Sep 29, 2025Accepted Sep 29, 2025, 2:54 AM EDTCIK 2024283Accession 0001213900-25-092607
Share

Company context

We are a pioneering provider of end-to-end innovative Hemp dosing solutions in the US that possesses the medical atomization and nebulizing background and sells nebulizers. We engage in the key activities in the Hemp cannabinoid E-vapors industry, including the research and development, formulation design, e-liquid production, e-liquid filling and e-liquid co-packing services. We believe our full-cycle operations and leading market position will position us to further capitalize on the growth potential of the Hemp cannabinoid E-vapors market in the United States.

Historical securities (1)

Recent company filings

  1. S-1/A filingMar 20, 2026
  2. RW filingDec 15, 2025
  3. RW filingDec 15, 2025
  4. S-1 filingNov 26, 2025
  5. 10-Q filingNov 14, 2025

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗